| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $57,485 | 2 | 25 |
Sells | $1,084,997 | 6 | 75 |
| Oki Mark K | Chief Financial Officer | 1 | $28,887 | 1 | $146,175 | $-117,288 |
| Stewart Richard Alistair | Chieve Executive Officer | 1 | $28,598 | 1 | $378,143 | $-349,545 |
| Wan Jerry | Principal Accounting Officer | 0 | $0 | 1 | $38,974 | $-38,974 |
| Xinos Jaime | Chief Commercial Officer | 0 | $0 | 1 | $57,766 | $-57,766 |
| JACOBS CINDY | President & CMO | 0 | $0 | 1 | $76,532 | $-76,532 |
| KING THOMAS BRAXTON | director | 0 | $0 | 1 | $387,407 | $-387,407 |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Over the last 12 months, insiders at Achieve Life Sciences, Inc. have bought $57,485 and sold $1.08M worth of Achieve Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Achieve Life Sciences, Inc. have bought $43,737 and sold $1.08M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Oki Mark K (Chief Financial Officer) — $28,887. Stewart Richard Alistair (Chieve Executive Officer) — $28,598.
The last purchase of 10,000 shares for transaction amount of $28,598 was made by Stewart Richard Alistair (Chieve Executive Officer) on 2025‑03‑17.
| 2025-09-18 | Sale | Stewart Richard Alistair | Chief Executive Officer | 129,501 0.2578% | $2.92 | $378,143 | +56.45% | |
| 2025-09-18 | Sale | Oki Mark K | Chief Financial Officer | 50,060 0.0997% | $2.92 | $146,175 | +56.45% | |
| 2025-09-04 | Sale | KING THOMAS BRAXTON | director | 139,858 0.2717% | $2.77 | $387,407 | +58.69% | |
| 2025-09-04 | Sale | JACOBS CINDY | President & CMO | 27,629 0.0537% | $2.77 | $76,532 | +58.69% | |
| 2025-09-04 | Sale | Xinos Jaime | Chief Commercial Officer | 20,854 0.0405% | $2.77 | $57,766 | +58.69% | |
| 2025-09-04 | Sale | Wan Jerry | Principal Accounting Officer | 14,070 0.0273% | $2.77 | $38,974 | +58.69% | |
| 2025-03-17 | Stewart Richard Alistair | Chieve Executive Officer | 10,000 0.0283% | $2.86 | $28,598 | +8.25% | ||
| 2025-03-17 | Oki Mark K | Chief Financial Officer | 10,000 0.0286% | $2.89 | $28,887 | +8.25% | ||
| 2024-03-04 | Bencich John | CEO | 10,000 0.0492% | $4.58 | $45,850 | +2.26% | ||
| 2024-03-04 | Stewart Richard Alistair | Executive Chairman | 10,000 0.0492% | $4.58 | $45,850 | +2.26% | ||
| 2023-05-30 | Bencich John | CEO | 5,000 0.0246% | $5.50 | $27,500 | -26.36% | ||
| 2022-11-18 | Bencich John | CEO | 22,000 – | $0 | $0 | +108.16% | ||
| 2021-05-27 | Bencich John | CEO | 6,000 0.0716% | $7.00 | $42,000 | -3.40% | ||
| 2019-06-11 | Sale | ARMISTICE CAPITAL, LLC | 10 percent owner | 312,145 4.6633% | $3.11 | $972,288 | -71.03% | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10 percent owner | 12,813 0.2335% | $3.80 | $48,689 | -71.03% | ||
| 2019-05-23 | Stewart Richard Alistair | Chairman & CEO | 17,500 0.2417% | $3.61 | $63,093 | -74.93% | ||
| 2016-08-19 | Sale | Bencich John | CFO | 2,760 0.0092% | $0.57 | $1,573 | -21.05% | |
| 2016-06-13 | Sale | Cormack Scott Daniel | President and CEO | 9,712 0.032% | $1.03 | $9,959 | -50.96% | |
| 2016-06-13 | Sale | JACOBS CINDY | EVP, CMO | 2,874 0.0095% | $1.03 | $2,947 | -50.96% | |
| 2016-03-15 | Sale | Cormack Scott Daniel | President and CEO | 24,066 0.0807% | $0.83 | $19,975 | -30.12% |
| KING THOMAS BRAXTON | director | 315142 0.592% | $1.32M | 0 | 1 | |
| Stewart Richard Alistair | Chief Executive Officer | 228875 0.4299% | $961,275.00 | 3 | 1 | <0.0001% |
| Oki Mark K | Chief Financial Officer | 127940 0.2403% | $537,348.00 | 1 | 1 | |
| JACOBS CINDY | President & CMO | 115585 0.2171% | $485,457.00 | 0 | 9 | |
| Xinos Jaime | Chief Commercial Officer | 74432 0.1398% | $312,614.40 | 0 | 1 | |
| Wan Jerry | Principal Accounting Officer | 32694 0.0614% | $137,314.80 | 0 | 1 | |
| COHEN STEVEN A/SAC CAPITAL MGMT LP | 10 percent owner | 1454752 2.7328% | $6.11M | 1 | 0 | |
| S A C CAPITAL MANAGEMENT L L C | 10 percent owner | 1454752 2.7328% | $6.11M | 1 | 0 | |
| SAC CAPITAL ADVISORS LLC | 10 percent owner | 1454752 2.7328% | $6.11M | 1 | 0 | |
| ARMISTICE CAPITAL, LLC | 10 percent owner | 1026000 1.9273% | $4.31M | 1 | 1 | <0.0001% |
| SAC CAPITAL ASSOCIATES LLC | 10 percent owner | 902376 1.6951% | $3.79M | 1 | 0 | |
| H.I.G. ONCOGENEX, INC. | 10 percent owner | 545512 1.0247% | $2.29M | 0 | 2 | |
| Cormack Scott Daniel | President and CEO | 129428 0.2431% | $543,597.60 | 1 | 12 | |
| Bencich John | CEO | 76724 0.1441% | $322,240.80 | 4 | 3 | <0.0001% |
| VENTURES WEST CAPITAL LTD | 10 percent owner | 41763 0.0785% | $175,404.60 | 0 | 1 | |
| Anderson Stephen Charles | CFO and Secretary | 13000 0.0244% | $54,600.00 | 3 | 0 | |
| MARTINO MICHAEL A | 11000 0.0207% | $46,200.00 | 0 | 10 | ||
| DUNBAR GEORGE W JR | director | 3250 0.0061% | $13,650.00 | 1 | 0 | |
| Lawrence Cameron William | Principal Financial Officer | 3050 0.0057% | $12,810.00 | 1 | 0 | |
| PARKER H STEWART | director | 3000 0.0056% | $12,600.00 | 1 | 0 | |
| IVY ROBERT E | director | 1700 0.0032% | $7,140.00 | 0 | 5 | |
| Wyrick Susan D. | PAO | 1312 0.0025% | $5,510.40 | 0 | 3 | |
| GOLDSTEIN JACK | director | 1000 0.0019% | $4,200.00 | 1 | 0 | |
| MATTINGLY MARTIN A | director | 1000 0.0019% | $4,200.00 | 1 | 0 | |
| WINSTEAD DWIGHT | director | 0 0% | $0 | 0 | 2 |
$8,708,580 | 93 | -5.38% | $232.07M | |
$1,323,997 | 34 | 0.21% | $246.09M | |
$22,017,898 | 24 | 39.19% | $229.57M | |
$6,915,275 | 21 | -32.61% | $251.22M | |
$110,580 | 16 | 14.52% | $246.36M | |
$245,302 | 15 | -4.08% | $211.32M | |
$4,701,608 | 14 | -4.34% | $238.85M | |
$1,037,470 | 13 | 78.00% | $204.87M | |
$170,425 | 10 | -16.01% | $216.26M | |
$145,296,407 | 8 | -0.98% | $188.48M | |
Achieve Life Sciences, Inc. (ACHV) | $272,982 | 6 | -28.53% | $223.58M |
$8,286,963 | 6 | 3.09% | $231.97M | |
$6,049,986 | 4 | -8.38% | $209.83M | |
$37,067 | 3 | -89.81% | $257.78M | |
$32,289,200 | 3 | -5.46% | $204.11M | |
$16,003,671 | 3 | 55.38% | $194.6M | |
$193,101 | 3 | -25.20% | $193.71M | |
$2,720,023 | 3 | -11.76% | $269.21M | |
$1,516,110 | 3 | 8.05% | $210.19M |
| Increased Positions | 42 | +52.5% | 4M | +15.34% |
| Decreased Positions | 36 | -45% | 15M | -56.13% |
| New Positions | 21 | New | 2M | New |
| Sold Out Positions | 21 | Sold Out | 3M | Sold Out |
| Total Postitions | 86 | +7.5% | 16M | -40.79% |
| Propel Bio Management, Llc | $18,819.00 | 7.14% | 3.79M | -2M | -38.46% | 2025-09-30 |
| Vanguard Group Inc | $12,235.00 | 4.64% | 2.46M | +311,925 | +14.51% | 2025-09-30 |
| Simplify Asset Management Inc. | $5,887.00 | 2.24% | 1.18M | 0 | 0% | 2025-09-30 |
| Marshall Wace, Llp | $3,851.00 | 1.46% | 774,853 | +774,853 | New | 2025-09-30 |
| Nantahala Capital Management, Llc | $3,225.00 | 1.22% | 648,885 | -250,000 | -27.81% | 2025-09-30 |
| Geode Capital Management, Llc | $2,520.00 | 0.96% | 506,977 | +144,777 | +39.97% | 2025-09-30 |
| Pathstone Holdings, Llc | $2,495.00 | 0.95% | 502,000 | +502,000 | New | 2025-09-30 |
| Raymond James Financial Inc | $2,268.00 | 0.86% | 456,372 | +161,314 | +54.67% | 2025-09-30 |
| Clearline Capital Lp | $2,243.00 | 0.85% | 451,219 | -875,040 | -65.98% | 2025-09-30 |
| Two Sigma Investments, Lp | $2,182.00 | 0.83% | 439,064 | +439,064 | New | 2025-09-30 |